We are proud to announce that NexPlasmaGen will be participating to the 6th edition of Invest-Tech, Québec’s must-attend event for innovative startups in AI, Deep Tech, and Med/Biotech! 📍 When &...
February 20, 2026, New member of NexPlasmaGen's Business Advisory Committee Montreal / February 20, 2026 – NexPlasmaGen is immensely proud to announce that Mr. Howard Hechler has joined NexPlasmaGen's Business Advisory...
Montreal / August 21, 2025 - NexPlasmaGen is pleased to announce that Mr. Suman Mallick has joined NexPlasmaGen board! Suman Mallick is a Managing Director at Keystone National Group, where is...
Montreal / July 24, 2025 – NexPlasmaGen is proud to announce that it has secured a patent in South Korea to protect its Convertible Plasma Jet (CPJ) technology for breast...
Montreal / April 25, 2025 – Clinical researchers at the University of Montreal Hospital Center (CHUM) have published in the journal BMC Cancer the clinical protocol for human safety trials initiated...
March 08, 2025, The CHUM site is activated to begin patient recruitment for safety clinical trials with NexPlasmaGen medical technology Montreal / March 08, 2025 - The Centre hospitalier de l'Université de...